DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Miao Y, Dobre D. Heerspink et al.
Increased serum potassium affects renal outcomes: A post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Diabetologia 2011;
54: 44-50 doi:10.1007/s00125-010-1922-6
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.